Delta-Fly Pharma (TSE:4598) Days Payable : 0.00 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Delta-Fly Pharma Days Payable?

Delta-Fly Pharma's average Accounts Payable for the three months ended in Dec. 2023 was 円0.00 Mil. Delta-Fly Pharma's Cost of Goods Sold for the three months ended in Dec. 2023 was 円0.00 Mil.

The historical rank and industry rank for Delta-Fly Pharma's Days Payable or its related term are showing as below:

TSE:4598's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 149.7
* Ranked among companies with meaningful Days Payable only.

Delta-Fly Pharma's Days Payable stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00). stayed the same

Delta-Fly Pharma Days Payable Historical Data

The historical data trend for Delta-Fly Pharma's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Delta-Fly Pharma Days Payable Chart

Delta-Fly Pharma Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Payable

Get a 7-Day Free Trial

Delta-Fly Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Delta-Fly Pharma's Days Payable

For the Biotechnology subindustry, Delta-Fly Pharma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Delta-Fly Pharma's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Delta-Fly Pharma's Days Payable distribution charts can be found below:

* The bar in red indicates where Delta-Fly Pharma's Days Payable falls into.

Delta-Fly Pharma Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Delta-Fly Pharma's Days Payable for the fiscal year that ended in Mar. 2023 is calculated as

	Days Payable (A: Mar. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Mar. 2022 )	+	Accounts Payable (A: Mar. 2023 ))	/	count )	/	Cost of Goods Sold (A: Mar. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Delta-Fly Pharma's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Delta-Fly Pharma Days Payable Related Terms

Thank you for viewing the detailed overview of Delta-Fly Pharma's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Delta-Fly Pharma (TSE:4598) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Delta-Fly Pharma Inc (TSE:4598) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

Miyajima Kinno 37-5, Tokushima Prefecture, Kawauchi Town, Tokushima, JPN, 771-0116

Website

http://www.delta-flypharma.co.jp

Delta-Fly Pharma Inc is a Japan-based company mainly engaged in the discovery and development of gentle anti-cancer agents with module technology.

Delta-Fly Pharma (TSE:4598) Headlines

No Headlines